NewsOncologywomen's cancers ESMO 2018: News in Oncology – Ovarian Cancer LBA36 - Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab…jwood@krftwrk.caNovember 14, 2018
Breast CancerMedical OncologyNewsOncology ESMO 2018: News in Oncology – Metastatic Breast Cancer 290O - Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant:…jwood@krftwrk.caNovember 14, 2018
Breast CancerMedical OncologyNewsOncology ESMO 2018: News in Oncology – Early Stage Breast Cancer LBA12_PR - PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with…jwood@krftwrk.caNovember 14, 2018
Lung CancerMedical OncologyNewsOncology ESMO 2018: News in Oncology – Metastatic Non-Small Cell Lung Cancer (NSCLC) LBA50 - Mechanisms of acquired resistance to first-line osimertinib: preliminary data from the phase III…jwood@krftwrk.caNovember 14, 2018
Medical OncologyNewsOncologySarcoma ESMO 2018: News in Oncology – Sarcoma LBA67 - Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: a French Sarcoma Group…jwood@krftwrk.caNovember 14, 2018